Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol
Peter MA Calverley,1 Fernando J Martinez,2 Leonardo M Fabbri,3 Udo-Michael Goehring,4 Klaus F Rabe5–71Clinical Science Center, University Hospital Aintree, Liverpool, United Kingdom; 2Department of Internal Medicine, University of Michigan, MI, USA; 3Department of Respiratory Diseases,...
Main Authors: | Calverley PM, Martinez FJ, Fabbri LM, Goehring UM, Rabe KF |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-06-01
|
Series: | International Journal of COPD |
Online Access: | http://www.dovepress.com/does-roflumilast-decrease-exacerbations-in-severe-copd-patients-not-co-a10163 |
Similar Items
-
Roflumilast: a review of its use in the treatment of COPD
by: Wedzicha JA, et al.
Published: (2016-01-01) -
Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD
by: Goehring Udo M, et al.
Published: (2011-01-01) -
Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD
by: Watz H, et al.
Published: (2018-03-01) -
Roflumilast is effective in reducing COPD related exacerbations and improving CAT score
by: Biagio Polla
Published: (2015-08-01) -
Does roflumilast induce phagocytic activity in COPD patients?
by: Ghosh B, et al.
Published: (2015-09-01)